MGRM READ THE FULL MGRM RESEARCH REPORT On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that ...

AUSTIN, TX / ACCESS Newswire / March 20, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI ...

Stock analysts at Roth Capital boosted their Q1 2025 earnings per share (EPS) estimates for shares of Monogram Orthopaedics ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hyperfine (HYPR – Research Report) and Monogram Orthopaedics ...

Stock analysts at Roth Capital upped their FY2028 earnings per share (EPS) estimates for Monogram Orthopaedics in a research ...

We have seen 18 institutional investors add shares of $MGRM stock to their portfolio, and 7 decrease their positions in their most recent quarter.

AUSTIN, TX / ACCESS Newswire / March 20, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial ...

Roth MKM raised the firm’s price target on Monogram Orthopaedics (MGRM) to $5.40 from $4 and keeps a Buy rating on the shares.Light Up your ...

Monogram gains FDA clearance for its robotic-assisted knee surgery system and plans clinical trials in India to expand ...

Q4 2024 Earnings Call Transcript March 12, 2025 Larry Holub: Good afternoon everyone. I’m Larry Holub, Director at MZ North America, and would like to welcome you to the Monogram Technologies fourth ...

Monogram Technologies Inc. ( NASDAQ: MGRM) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Larry Holub - Investor Relations Benjamin Sexson - Chief Executive Officer Noel Knape - Chief ...